These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation. Alibolandi M, Abnous K, Sadeghi F, Hosseinkhani H, Ramezani M, Hadizadeh F. Int J Pharm; 2016 Mar 16; 500(1-2):162-78. PubMed ID: 26802496 [Abstract] [Full Text] [Related]
25. Epithelial cell adhesion molecule aptamer conjugated PEG-PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro. Alibolandi M, Ramezani M, Sadeghi F, Abnous K, Hadizadeh F. Int J Pharm; 2015 Feb 01; 479(1):241-51. PubMed ID: 25529433 [Abstract] [Full Text] [Related]
27. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment. Pan C, Liu Y, Zhou M, Wang W, Shi M, Xing M, Liao W. Int J Nanomedicine; 2018 Feb 01; 13():1119-1137. PubMed ID: 29520140 [Abstract] [Full Text] [Related]
30. Characterization and Evaluation of Bone-Derived Nanoparticles as a Novel pH-Responsive Carrier for Delivery of Doxorubicin into Breast Cancer Cells. Haque ST, Islam RA, Gan SH, Chowdhury EH. Int J Mol Sci; 2020 Sep 14; 21(18):. PubMed ID: 32937817 [Abstract] [Full Text] [Related]
31. Targeted Therapy of Colon Cancer by Aptamer-Guided Holliday Junctions Loaded with Doxorubicin. Yao F, An Y, Li X, Li Z, Duan J, Yang XD. Int J Nanomedicine; 2020 Sep 14; 15():2119-2129. PubMed ID: 32280210 [Abstract] [Full Text] [Related]
34. Advancing targeted combination chemotherapy in triple negative breast cancer: nucleolin aptamer-mediated controlled drug release. Ma Y, Xie D, Chen Z, Shen X, Wu X, Ding F, Ding S, Pan Y, Li F, Lu A, Zhang G. J Transl Med; 2024 Jul 01; 22(1):604. PubMed ID: 38951906 [Abstract] [Full Text] [Related]
36. A multi-storey DNA nanostructure containing doxorubicin and AS1411 aptamer for targeting breast cancer cells. Yaghoobi E, Zavvar T, Ramezani M, Alibolandi M, Rahimzadeh Oskuei S, Zahiri M, Alinezhad Nameghi M, Abnous K, Taghdisi SM. J Drug Target; 2022 Dec 01; 30(10):1106-1112. PubMed ID: 35736221 [Abstract] [Full Text] [Related]
37. Targeted delivery of Doxorubicin by folic acid-decorated dual functional nanocarrier. Lu J, Zhao W, Huang Y, Liu H, Marquez R, Gibbs RB, Li J, Venkataramanan R, Xu L, Li S, Li S. Mol Pharm; 2014 Nov 03; 11(11):4164-78. PubMed ID: 25265550 [Abstract] [Full Text] [Related]
38. A nuclear targeted Dox-aptamer loaded liposome delivery platform for the circumvention of drug resistance in breast cancer. Li X, Wu X, Yang H, Li L, Ye Z, Rao Y. Biomed Pharmacother; 2019 Sep 03; 117():109072. PubMed ID: 31202169 [Abstract] [Full Text] [Related]
39. Hybrid Liposome-MSN System with Co-Delivering Potential Effective Against Multidrug-Resistant Tumor Targets in Mice Model. Yang Y, Yang S, Zhang B, Wang J, Meng D, Cui L, Zhang L. Int J Nanomedicine; 2024 Sep 03; 19():8949-8970. PubMed ID: 39246424 [Abstract] [Full Text] [Related]